Komunikaty PR

AI In Biotechnology Global Market Report 2025: Unprecedented Growth Driven By Technological Advancement

2025-06-10  |  19:55:04
The Business Research Company

The Business Research Company

The Business Research Company's AI In Biotechnology Global Market Report 2025: Unprecedented Growth Driven By Technological Advancement

It will grow to $13.40 billion in 2029 at a compound annual growth rate (CAGR) of 24.6%.”
— The Business Research Company

LONDON, GREATER LONDON, UNITED KINGDOM, June 10, 2025 /EINPresswire.com/ -- The Business Research Company’s Latest Report Explores Market Driver, Trends, Regional Insights - Market Sizing & Forecasts Through 2034

The AI in biotechnology market size has grown exponentially in recent years. Projected to escalate from $4.46 billion in 2024 to $5.56 billion in 2025, achieving a compound annual growth rate CAGR of 24.8%, the market's impressive growth can be attributed to increasing computational power, growth of AI-driven drug discovery, growth of AI in microbiome research, rise of AI in regenerative medicine, and increasing use of AI in agricultural biotechnology.

What's Fueling The Growth Of The AI In Biotechnology Market Going Forward?

Anticipating significant growth in the next few years, the AI in biotechnology market size is projected to hit $13.40 billion in 2029, at a CAGR of 24.6%. This expected growth in the forecast period is driven by the rising adoption of AI, increasing investment in AI-biotech startups, growing adoption of AI in toxicology studies, the rise of AI-driven predictive models for cancer research, and the growth of AI-driven drug repurposing. Additionally, advancements in deep learning and neural networks, integration of AI in genomics and proteomics, advancements in AI-driven CRISPR gene editing, AI integration in pharmacovigilance, and the development of AI-based companion diagnostics are expected to shape the market trends in the forecast period.

Get Your Free Sample Market Report:
https://www.thebusinessresearchcompany.com/sample_request?id=23609&type=smp

What’s Driving The AI In Biotechnology Market Growth?

The increasing adoption of AI is expected to continue propelling the growth of the AI in biotechnology market. Artificial intelligence, the simulation of human intelligence processes by machines, particularly computer systems, enhances efficiency, accuracy, and decision-making across industries. It enables the automation of complex data analysis, ensuring consistent precision. Within the biotechnology sector, AI accelerates drug discovery, optimizes research processes, and facilitates advanced predictive modeling for improved healthcare outcomes.

What Key Player Strategies Are Driving The AI In Biotechnology Market?

In the AI in biotechnology market, key players include Google LLC, Pfizer Inc., Johnson & Johnson Services Inc., F. Hoffmann-La Roche Ltd., International Business Machines Corporation IBM, Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca Plc, Abbott Laboratories, Novartis AG, Roivant Sciences Ltd., Gilead Sciences Inc., NVIDIA Corporation, Amgen Inc., Novo Nordisk A/S, Merck KGaA, Biogen Inc., CareDx Inc., Clario Inc., BenevolentAI Limited, Recursion Pharmaceuticals Inc., Insilico Medicine Inc., and Genesis Therapeutics Inc. These companies are paving the way for revolutionary advancements in biotechnology by utilizing artificial intelligence.

Order Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/ai-in-biotechnology-global-market-report

What Are The Emerging Trends In The AI In Biotechnology Market?

A recent emerging trend in the AI in biotechnology market is the development of AI-powered antibody discovery platforms. This technology-driven system utilizes artificial intelligence to rapidly identify and optimize therapeutic antibodies, facilitating faster, more cost-effective drug development and improved biopharmaceutical outcomes. In February 2023, AION Labs, an Israel-based venture studio, launched DenovAI, a platform for de novo discovery of therapeutic antibodies. Combining machine learning with computational biophysics, DenovAI allows for enhanced precision, broader sequence diversity, and significantly reduced development timelines.

How Is The AI In Biotechnology Market Segmented?

In terms of market segmentation, the AI in biotechnology market report has outlined the following:
1 By Component: Software, Hardware, Services
2 By Application: Drug Discovery And Development, Clinical Trials And Optimization, Medical Imaging, Diagnostics, Other Applications
3 By End User: Pharmaceutical Companies, Biotechnology Companies, Academic And Research Institutes, Healthcare Providers, Contract Research Organization CRO And Contract Development And Manufacturing Organization CDMO, Other End Users

What Are The Regional Insights In The AI In Biotechnology Market?

With respect to regional insights, North America holds the position of the largest region in the AI in biotechnology market as of 2024. Asia-Pacific, however, is expected to be the fastest-growing region in the predicted period. The regions covered in the AI in biotechnology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:
AI In Telecommunication Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/ai-in-telecommunication-global-market-report
AI In Medical Imaging Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/ai-in-medical-imaging-global-market-report
AI In Energy Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/ai-in-energy-global-market-report

About The Business Research Company
The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. With over 15000+ reports from 27 industries covering 60+ geographies, we provide a unique combination of in-depth secondary research and unique insights from industry leaders.

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info|tbrc.info| |info|tbrc.info
Visit us on social media:
LinkedIn
Facebook
X

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Newseria nie ponosi odpowiedzialności za treści oraz inne materiały (np. infografiki, zdjęcia) przekazywane w „Biurze Prasowym”, których autorami są zarejestrowani użytkownicy tacy jak agencje PR, firmy czy instytucje państwowe.
Ostatnio dodane
komunikaty PR z wybranej przez Ciebie kategorii
EIN Newswire BRAK ZDJĘCIA
2025-07-17 | 19:55:06

LAIA Celebrates 10 Years of Empowering Communities Through Immigration Document Preparation

LAIA 10 Year Aniversary FlyerThe Latin American Immigration Association celebrates a decade of training thousands in ethical, non-legal immigration document preparation.This milestone isn’t just about numbers, it’s about lives
EIN Newswire BRAK ZDJĘCIA
2025-07-17 | 19:55:06

VETS2INDUSTRY Teams Up with Signal Health Group and Defenders Gateway to Support Transitioning Veterans

Collaboration is the key to solving the most pressing challenges our veterans and their families face.”— Hahn March, CEO, VETS2INDUSTRYHOUSTON, TX, UNITED STATES, July 17, 2025 /EINPresswire.com/ -- VETS2INDUSTRY is proud to announce
EIN Newswire BRAK ZDJĘCIA
2025-07-17 | 19:55:06

Free Community Health Fair Brings Comprehensive Wellness Services to Local Residents

Liberty Temple Chicago 2025 Health FairEvent Offers No-Cost Health Screenings, Professional Services, and Life-Saving EducationWe want this to be more than just a health screening event. It's about building a healthier, more connected

Kalendarium

Więcej ważnych informacji

Jedynka Newserii

Jedynka Newserii

Kongres Profesjonalistów Public Relations

Handel

Handel

Nie tylko konsumenci starają się kupować bardziej odpowiedzialne. Część firm już stawia na to mocny nacisk

Kwestie równoważonych zakupów stają się elementem strategii ESG. Dostawy energii, zamówienia surowców i materiałów do produkcji czy elementów wyposażenia biur – na każdym etapie swoich zakupów firmy mogą dziś decydować między opcjami bardziej i mniej zrównoważonymi. Dotyczy to także zamówień rzeczy codziennego użytku dla pracowników czy środków czystości – wskazują eksperci Lyreco, e-sklepu, który prowadzi sprzedaż produktów do biur, pokazując ich wpływ na środowisko czy efektywność pracy.

Prawo

Unia Europejska wzmacnia ochronę najmłodszych. Parlament Europejski chce, by test praw dziecka był nowym standardem w legislacji

Parlament Europejski chciałby tzw. testu praw dziecka dla każdego aktu prawnego wychodzącego z Komisji Europejskiej. – Każda nowa legislacja Unii Europejskiej powinna być sprawdzana pod kątem wpływu na prawa dziecka – zapowiada Ewa Kopacz, wiceprzewodnicząca PE. Jak podkreśla, głos dzieci jest coraz lepiej słyszalny w UE i jej różnych politykach. Same dzieci wskazują na ważne dla siebie kwestie, którymi UE powinna się zajmować. Wśród nich są wyzwania w obszarze cyfrowym i edukacyjnym.

Partner serwisu

Instytut Monitorowania Mediów

Szkolenia

Akademia Newserii

Akademia Newserii to projekt, w ramach którego najlepsi polscy dziennikarze biznesowi, giełdowi oraz lifestylowi, a  także szkoleniowcy z wieloletnim doświadczeniem dzielą się swoją wiedzą nt. pracy z mediami.